Immune Cell Engineering: Targeting Checkpoint Inhibitors

In course

Ipsum amet non et sint duis cupidatat. Sunt laborum ipsum eiusmod nostrud deserunt adipisicing elit ex deserunt duis qui laborum enim esse. Duis dolor veniam laboris proident adipisicing. Enim veniam laboris sit laboris laboris voluptate commodo deserunt. Proident aliqua exercitation dolor nisi eu aliquip aliquip est.

Description

This lecture covers the engineering of immune cells for cancer immunotherapy, focusing on targeting checkpoint inhibitors using various delivery techniques such as liposomes and microneedles. It discusses strategies for better drug release control and the use of platelets for post-surgery checkpoint inhibitor delivery.

Instructor

pariatur qui

Proident laborum cupidatat qui ea quis nisi ut consectetur amet eiusmod consequat. Ad aliquip id cillum ipsum ea consequat fugiat nostrud ipsum laborum cupidatat non qui sunt. Officia nisi eiusmod reprehenderit amet fugiat veniam. Fugiat occaecat qui cupidatat deserunt cillum laborum esse veniam reprehenderit deserunt. Ut cillum ad excepteur nulla. Dolore ullamco anim in enim id minim ipsum est pariatur. Qui veniam cupidatat enim voluptate adipisicing magna cillum elit ut quis amet commodo consequat sint.

Official source

https://mediaspace.epfl.ch/media/0_qhuybxcu

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Ontological neighbourhood

Health sciences

Immunology: Immune system

Cardiology: Cardiovascular disease

Neurology: Topics in neurology

Biology

Cell biology: Cancer, Blood, Cell signaling

Biological engineering

Biomedical engineering: Genetic engineering

Related lectures (390)